Besides this mechanistic hypothesis, these data also suggest that a pharmacological intervention aimed at increasing plasmin in the CNS, or reducing the level of its inhibitor PAI‐1, could represent a new and alternative strategy to treat dementia associated with various neurological disorders. The gene discussed is SERPINE1; the disease is nervous system disorder.